Literature DB >> 13972634

Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures.

M PUZISS, L C MANNING, J W LYNCH, I ABELOW, G G WRIGHT.   

Abstract

A production-proving test was described for the preparation, by the anaerobic culture method, of large volumes of culture filtrate containing immunologically potent protective antigen of Bacillus anthracis. The process consisted of the anaerobic culture of a selected production strain in a chemically defined medium. The culture was then clarified and sterilized by filtration through sintered-glass filters. The sterile culture filtrate was adsorbed onto a preformed aluminum hydroxide gel, and the stabilized gel-antigen complex was concentrated. The final product had high immunizing potency, as shown by both in vivo and in vitro assays, and was well tolerated in man. Stability of the product to accelerated aging was good, and storage at 4 C for 1 year caused only a minor loss in protective activity. Large volumes of the highly antigenic gel-adsorbed protective antigen were readily produced by the method described.

Entities:  

Keywords:  ANTIGENS; BACILLUS ANTHRACIS

Mesh:

Substances:

Year:  1963        PMID: 13972634      PMCID: PMC1057997          DOI: 10.1128/am.11.4.330-334.1963

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  7 in total

1.  An agar-diffusion method for titrating Bacillus anthracis immunizing antigen and its application to a study of antigen production.

Authors:  C B THORNE; F C BELTON
Journal:  J Gen Microbiol       Date:  1957-10

2.  Immunizing activity of alum-precipitated protective antigen of Bacillus anthracis in cattle, sheep, and swine.

Authors:  A S SCHLINGMAN; H B DEVLIN; G G WRIGHT; R J MAINE; M C MANNING
Journal:  Am J Vet Res       Date:  1956-04       Impact factor: 1.156

3.  Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen.

Authors:  G G WRIGHT; T W GREEN; R G KANODE
Journal:  J Immunol       Date:  1954-12       Impact factor: 5.422

4.  Field Evaluation of a Human Anthrax Vaccine.

Authors:  P S Brachman; H Gold; S A Plotkin; F R Fekety; M Werrin; N R Ingraham
Journal:  Am J Public Health Nations Health       Date:  1962-04

5.  Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis.

Authors:  G G WRIGHT; M PUZISS; W B NEELY
Journal:  J Bacteriol       Date:  1962-03       Impact factor: 3.490

6.  Studies on immunity in anthrax. VII. Carbohydrate metabolism of Bacillus anthracis in relation to elaboration of protective antigen.

Authors:  M PUZISS; G G WRIGHT
Journal:  J Bacteriol       Date:  1959-07       Impact factor: 3.490

7.  Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man.

Authors:  M PUZISS; G G WRIGHT
Journal:  J Bacteriol       Date:  1963-01       Impact factor: 3.490

  7 in total
  39 in total

1.  Search for correlates of protective immunity conferred by anthrax vaccine.

Authors:  S Reuveny; M D White; Y Y Adar; Y Kafri; Z Altboum; Y Gozes; D Kobiler; A Shafferman; B Velan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  Occurrence, recognition, and reversion of spontaneous, sporulation-deficient Bacillus anthracis mutants that arise during laboratory culture.

Authors:  Inka Sastalla; Stephen H Leppla
Journal:  Microbes Infect       Date:  2011-11-28       Impact factor: 2.700

Review 3.  Development of an improved vaccine for anthrax.

Authors:  Stephen H Leppla; John B Robbins; Rachel Schneerson; Joseph Shiloach
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

4.  The Gordon Wilson lecture: using genetic medicine to regenerate diseased organs and protect against the hostile environment.

Authors:  Timothy P O'Connor; Ronald G Crystal
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

Review 5.  Genetic medicine strategies to protect against bioterrorism.

Authors:  Julie L Boyer; Ronald G Crystal
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

6.  Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.

Authors:  B E Ivins; S L Welkos; G B Knudson; S F Little
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

7.  Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants.

Authors:  L C Iacono-Connors; C S Schmaljohn; J M Dalrymple
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

8.  Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.

Authors:  Melissa L Nguyen; Sherry R Crowe; Sridevi Kurella; Simon Teryzan; Brian Cao; Jimmy D Ballard; Judith A James; A Darise Farris
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

9.  Mechanism of HERG potassium channel inhibition by tetra-n-octylammonium bromide and benzethonium chloride.

Authors:  Yan Long; Zuoxian Lin; Menghang Xia; Wei Zheng; Zhiyuan Li
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-08       Impact factor: 4.219

10.  Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.

Authors:  L C Iacono-Connors; S L Welkos; B E Ivins; J M Dalrymple
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.